Arena Investors »

Elicio Therapeutics shares owned by Arena Investors

Quarter-by-quarter ownership of Elicio Therapeutics (ELTX) shares owned by Arena Investors from 13F filings

Historical chart of Arena Investors investment in Elicio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Elicio Therapeutics held by Arena Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elicio Therapeutics by Arena Investors

Quarter filed Position value Share count Share price at filing
2024-06-30 $206k 50k 4.11

More positions owned by Arena Investors

Beyond Meat Option Put Option
Beyond Meat Note (Principal)
HashiCorp Equity (HCP)
Invesco QQQ Trust Series 1 Option Put Option
Spdr S&p500 Etf Trust Option Put Option
iShares J.P. Morgan USD Emerging Markets Bond ETF Option Put Option
Prime Number Holding Equity (NCNC)
iShares iBoxx High Yield Corporate Bond ETF Option Put Option
Elicio Therapeutics Equity (ELTX)
Edible Garden Warrant (EDBLW)
Phoenix Biotech Acquisition Equity (CERO)
Yotta Acquisition Corp Rights (YOTAR)
Tenzing Acquisition Corp Warrant (RVPHW)
Kernel Group Holdings Warrant (QQQ)
Oxbridge Acquisition Corp Warrant (JTAIW)

View all positions for Arena Investors

Top funds holding Elicio Therapeutics

Vanguard Group
Armistice Capital
Geode Capital Management
CM Management
Arena Investors
Hudson Bay Capital Management
State Street Corporation
BlackRock
Meyer Handelman
Bridgeway Capital Management
Warberg Asset Management
Atlantic Trust
Steward Partners Investment Advisory
National Bank Of Canada /fi/
Bank of America Corporation

View all funds holding Elicio Therapeutics